CTRL Therapeutics
Chicago, United States · Founded 2023
- Headquarters
- Chicago, Illinois
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- ctrl-therapeutics.com
- Last Round
- Series ASep 2024
- Rounds
- 2
About
CTRL Therapeutics is developing a first-of-its-kind polyclonal cell therapy platform to treat solid tumors using circulating tumor-reactive lymphocytes (cTRLs) isolated from blood rather than tumor tissue. The company's proprietary IsoQore™ cell-sorting platform enables efficient extraction of millions of cTRLs through a simple blood draw, avoiding invasive surgical procedures required by traditional TIL therapies. CTRL's lead product, cTRL-001, aims to provide a scalable, outpatient-ready solution for a broad range of solid tumors.
Summary
CTRL Therapeutics is a Life Sciences company based in Chicago, United States, founded in 2023. Its most recent funding was a Series A round in Sep 2024. Investors include General Catalyst, Portal Innovations and Intermountain Healthcare.
Funding History
Sep 2024
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ctrl-therapeutics"><img src="https://indexed.vc/api/badge/company/ctrl-therapeutics" alt="CTRL Therapeutics on Indexed.vc" width="260" height="76" /></a>